Skip to content

Inogen INGN Operating Cash Flow

Operating Cash Flow at other companies

ResMed logo
ResMedRMD
$554.13M-4.2%
AdaptHealth logo
AdaptHealthAHCO
$93.72M-1.9%
Viemed Healthcare, Inc. logo
Viemed Healthcare, Inc.VMD
$8.07M+183%
Savara logo
SavaraSVRA
-$33.05M-21.5%
Tactile Systems Technology logo
Tactile Systems TechnologyTCMD
-$339K-181%
iRhythm Holdings, Inc.
 logo
iRhythm Holdings, Inc. IRTC
-$26.17M-232%

Other financials

Income statement

See full
Revenue$85.1M+3.4%
Gross profit$44.9M+1.7%
Operating income-$9.3M-21.9%
Net income-$8.3M-34.8%
EPS (diluted)-$0.30-20.0%

Balance sheet

See full
Cash & equivalents$93.1M-21.7%
Total debt$16.9M-11.9%
Total equity$182.9M-7.6%
Total assets$285.9M-7.3%

Cash flow

See full
CapEx$210.0K-28.1%
Free cash flow-$6.9M+59.6%

Valuation

See full
Market cap$174.63M-9.7%
Enterprise value$98.45M-9.5%
P/S0.5×-0.1×

Profitability

See full
Gross margin52.8%-2.6pp
Operating margin-9.1%-0.8pp
Net margin-7.1%-0.8pp
FCF margin0.4%

Returns & leverage

See full
Return on equity-13.1%-0.9pp
Debt / equity0.1×0.0×
Current ratio3.1×0.0×

Where this comes from

Reported directly by Inogen in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: Inogen’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Inogen's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Inogen's operating cash flow?
Inogen (INGN) reported operating cash flow of -$6.69M in Q1 2026.
How has Inogen's operating cash flow changed year-over-year?
Inogen's operating cash flow increased by 60.2% year-over-year, from -$16.79M to -$6.69M.
What does operating cash flow mean?
Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.